All News
Two key drivers of hereditary kidney cancer are identified
Laboratory Animal Sciences ProgramPosted 7/13/2023An international research collaboration including scientists from the Frederick National Laboratory has identified two key drivers of a hereditary kidney cancer and opened new possibilities for therapeutic approaches to a disease whose current treatment is largely surgerical.
The scientists implicated two proteins that work cooperatively to drive tumor formation in Birt-…
Panel at BIO International Convention provides navigation tips and resources to avoid AI pitfalls
Partnership Development OfficePosted 7/10/2023Artificial intelligence has rapidly become a buzzword that evokes fear and hope. A recent panel discussion dug into this issue at the 2023 BIO International Convention, one of the world’s largest biotech partnering events, attracting more than 14,000 biotech leaders to Boston this year.
The discussion, “Is Your Billion-Dollar Oncology AI Cutting-Edge Technology or Is It…
National Science Foundation grant provides PhD student experience with machine learning under FNL mentor
Cancer Data Science Initiatives, Partnership Development Office, Cancer Research Technology ProgramPosted 6/27/2023
When Chloe Thangavelu, a Ph.D. student at the University of California, Irvine, received funding from the National Science Foundation for a six-month internship, she eagerly set out to find an internship where she could combine her biological and computational expertise and gain experience with machine learning.
That’s why she reached out to the Frederick National…
Clinical Safety Office supports patient safety monitoring for mpox clinical trial in Africa
Clinical Monitoring Research ProgramPosted 6/13/2023
A new clinical study in Africa is testing an antiviral treatment for patients with mpox (previously known as monkeypox). This is the latest project for the Frederick National Laboratory for Cancer Research’s Clinical Monitoring Research Program, which specializes in supporting clinical trials in domestic and international settings.
The Clinical Safety Office, under…
First study of people with HIV on long-term ART shows cognitive decline
Clinical Research DirectoratePosted 6/7/2023People with HIV on long-term antiretroviral therapy show signs of brain damage and cognitive impairment on a battery of imaging, laboratory, and functional tests, and they report a greater degree of difficulty with the routine tasks of everyday life, according to a new study.
The study, published in April in the journal Neurology, is the first to gauge cognitive changes in…
Blood-based tests may offer noninvasive way to determine immunotherapy candidates
Molecular Characterization Laboratory, Clinical Research DirectoratePosted 6/1/2023Blood-based tests that identify cancer markers may offer a noninvasive way to determine if a patient is a candidate for immunotherapy, according to a Frederick National Laboratory for Cancer Research study to be presented at the 2023 Annual Meeting of the American Society for Clinical Oncology, June 2-6 in Chicago.
Chris Karlovich, Ph.D. of the Frederick National…
Biotech Connector recap: Shedding light on human maladies
Posted 6/1/2023Three scientists from the region presented innovative imaging techniques and discussed how they are leveraging them to advance cancer research and ultimately improve human health at the Biotech Connector seminar on Wednesday, May 17, the second in this year’s series sponsored by the Frederick National Laboratory for Cancer Research and the Frederick County Chamber of Commerce…
A single dose of HPV vaccine may provide adequate protection
Vaccine, Immunity, and Cancer DirectoratePosted 5/31/2023A growing body of evidence suggests that a single dose of vaccine against cancer-causing human papilloma virus (HPV) may protect as well as the standard two-or-more dose regimen. This would make it easier to protect more women, especially in low-income areas where vaccine access is scarce.
A study published recently in The Lancet Global Health strengthens the case, with a…
Three projects awarded LDER funding to explore innovations
Partnership Development OfficePosted 5/22/2023Each year, the Frederick National Laboratory offers its scientists an opportunity to compete for funding to conduct the research they view as critical to advance biomedical research but is outside the scope of their daily research activities.
This year, three proposals earned funding through the program, known as the Laboratory Directed Exploratory Research (LDER) program…
FNL joins BIO International panel to tackle tough questions about AI in oncology, promote partnerships
Partnership Development OfficePosted 5/19/2023
Is your billion-dollar oncology artificial intelligence (AI) cutting-edge technology, or is it artificial ignorance? That’s the question Frederick National Laboratory’s Maggie Scully, Ph.D., and a panel of industry experts seek to tackle at the BIO International Convention in Boston on June 7.
Karim Budhwani, Ph.D., DLA, CEO-scientist of CerFlux, Inc., who will be…